A Study to Evaluate HMPL-306 in Patients With IDH1or IDH2-mutated Acute Myeloid Leukemia

NCT06387069 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

316

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: HMPL-306 Regimen
DRUG: Salvage Chemotherapy Regimen

Sponsor

Hutchmed